On-demand vaginal contraceptive gel in USJune 10, 2020
The USFDA has approved the first non-hormonal contraceptive vaginal gel for use as an on-demand method of contraception.
Composed of lactic acid, citric acid and potassium bitartrate, the gel demonstrated an efficacy rate of 86.3% during a phase 3 clinical trial for the prevention of pregnancy. Phexxi is a vaginal pH regulator contraceptive designed to maintain vaginal pH within the normal range of 3.5 to 4.5 – an acidic environment that is inhospitable to sperm.
Evofem Biosciences expects to launch Phexxi in early September alongside the Phexxi Concierge Experience, a comprehensive patient and healthcare provider telemedicine support system.